[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# Sanofi (SNY)

FDA launches fresh safety scrutiny of approved RSV therapies for infants, impacting Merck, Sanofi, and AstraZeneca, following concerns raised by vaccine skeptics.

### About Sanofi
Sanofi is a global pharmaceutical company.  
Sanofi uses the ticker $SNY for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Sanofi (SNY) market dominance near a 52-week low at XXXXXXX.
- Sanofi (SNY) trading volume is up XXXXXX% from the previous week.
- Sanofi (SNY) social dominance is up XXXXX% from the previous week.
- Sanofi (SNY) Galaxy Score™ is up XXXXX% from the previous week.
- Sanofi (SNY) sentiment is up XXXXX% from the previous week.
- Sanofi (SNY) posts created is up XXXXX% from the previous week.

### Price: $XX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:sanofi/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/sanofi/time-series/close.tsv)  
Sanofi's stock price is experiencing downward pressure, likely influenced by the ongoing tax fraud investigation and headquarters raid, which appears to be outweighing positive news regarding Dupixent sales and EU approval.  

24-Hour: XXXX%
7-Day: -XXXX%
30-Day: -XXXX%

1-Year High: $XXXXX on 2025-03-06  
1-Year Low: $XXXXX on 2025-09-25  
  
  
### AltRank: XXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:sanofi/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/sanofi/time-series/alt_rank.tsv)  
Sanofi (SNY) is currently AltRank #508 based on combined combined social and market metrics
Daily Average: XXXXX  
X Week: XXX +72  
X Month: XXX -XXX  
X Months: XXX -XXX  
X Year: XXX -XXX  
1-Year High: XXXXX on 2025-07-06  
1-Year Low: XX on 2025-09-05  
  
  
### Galaxy Score: XXXXX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:sanofi/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/sanofi/time-series/galaxy_score.tsv)  
Current Value: XXXXX  
Daily Average: XX  
X Week: XX +11  
X Month: XX -XX  
X Year: XX -X  
1-Year High: XX on 2025-10-02  
1-Year Low: XX on 2025-09-24  
  
  
### Engagements: XXXXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:sanofi/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/sanofi/time-series/interactions.tsv)  
Current Value: XXXXXXX  
Daily Average: XXXXXXX  
X Week: XXXXXXX -XX%  
X Month: XXXXXXXXX -XXXX%  
X Months: XXXXXXXXXX +189%  
X Year: XXXXXXXXXX -XX%  
1-Year High: XXXXXXXXX on 2025-11-01  
1-Year Low: XXXXX on 2025-02-02  

Engagements by network (24h):
News: XXX
Reddit: XXX
TikTok: XXXXX
X: XXXXXX
YouTube: XXXXXX

  
  
### Mentions: XXX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:sanofi/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/sanofi/time-series/posts_active.tsv)  
Current Value: XXX  
Daily Average: XXX  
X Week: XXX -XX%  
X Month: XXXXX -XX%  
X Months: XXXXXX +79%  
X Year: XXXXXX +60%  
1-Year High: XXXXX on 2025-08-07  
1-Year Low: XXX on 2025-01-27  

Mentions by network (24h):
News: XX
Reddit: XX
TikTok: XXX
X: XXXXX
YouTube: XXX

  
  
### Creators: XXX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:sanofi/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/sanofi/time-series/contributors_active.tsv)  
XXX unique social accounts have posts mentioning Sanofi (SNY) in the last XX hours which is down XX% from XXX in the previous XX hours
Daily Average: XXX  
X Week: XXX -XX%  
X Month: XXXXX -XX%  
X Months: XXXXX +70%  
X Year: XXXXX +35%  
1-Year High: XXX on 2025-09-04  
1-Year Low: XX on 2025-01-27  

The most influential creators that mention Sanofi in the last XX hours

| Creator                                                              | Rank | Followers | Posts | Engagements |
| -------                                                              | ---- | --------- | ----- | ----------- |
| [@sanofi](/creator/youtube/sanofi)                                   | X    | XXXXXX    | X     | XXXXXX      |
| [@OpenOutcrier](/creator/twitter/OpenOutcrier)                       | X    | XXXXXX    | X     | XXXXX       |
| [@cp_option](/creator/twitter/cp_option)                             | X    | XXX       | X     | XXX         |
| [@americanlungassociation](/creator/youtube/americanlungassociation) | X    | XXXXXX    | X     | XXX         |
| [@notreload_ai](/creator/twitter/notreload_ai)                       | X    | XXXXX     | X     | XXX         |
| [@Quantumup1](/creator/twitter/Quantumup1)                           | X    | XXXXX     | X     | XXX         |
| [@doepke_michel](/creator/twitter/doepke_michel)                     | X    | XXXXX     | X     | XXX         |
| [@Bionavgator](/creator/twitter/Bionavgator)                         | X    | XXX       | X     | XXX         |
| [@ALT_Nicholson](/creator/twitter/ALT_Nicholson)                     | X    | XXX       | X     | XXX         |
| [@grok](/creator/twitter/grok)                                       | XX   | XXXXXXXXX | XX    | XXX         |

[View More](/list/creators/sanofi/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:sanofi/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/sanofi/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% +10%  
X Month: XX% +7%  
X Months: XX% +11%  
X Year: XX% +8%  
1-Year High: XX% on 2025-11-02  
1-Year Low: XX% on 2025-08-02  

Most Supportive Themes:
- Dupixent Sales Driving Growth: (20%) Sanofi's drug Dupixent is a significant revenue driver, nearing $X billion in sales, indicating strong market performance and product success.
- India Market Expansion: (15%) Sanofi is actively expanding its presence in India through new product launches and strategic portfolio development, signaling a focus on emerging markets.
- Partnerships and Acquisitions: (10%) The company is engaging in strategic partnerships, such as with Novavax, and exploring potential acquisitions, demonstrating a proactive approach to growth and innovation.
  
Most Critical Themes:
- Vaccine Concerns: (5%) Despite overall positive financial results, Sanofi is facing some negative sentiment or 'buzz' surrounding its vaccine products.
- Potential Acquisition Targets: (5%) Discussions around potential acquisitions, like Abgenix, suggest strategic shifts or potential divestitures that could impact the company's future.
  
  
  
### Social Dominance: XXXXX%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:sanofi/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/sanofi/time-series/social_dominance.tsv)  
Current Value: XXXXX%  
Daily Average: XXXXX%  
X Week: XXXXX% +0.03%  
X Month: XXXXX% +0.03%  
X Months: XXXXX% +0.031%  
X Year: XXXXX% +0.027%  
1-Year High: XXXXX% on 2024-12-18  
1-Year Low: XXXXX% on 2025-04-07  
  
  
### Market Dominance: XXXXX%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:sanofi/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/sanofi/time-series/market_dominance.tsv)  
Current Value: XXXXX%  
Daily Average: X%  
1-Year High: XXXX% on 2025-03-31  
1-Year Low: XXXXX% on 2025-12-09  
  
  
### Market Cap: $XXXXXXXXXXXXXXX
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:sanofi/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/sanofi/time-series/market_cap.tsv)  
Current Value: $XXXXXXXXXXXXXXX  
Daily Average: $XXXXXXXXXXXXXXX  
X Week: $XXXXXXXXXXXXXXX -$3.50%  
X Month: $XXXXXXXXXXXXXXX -$3.30%  
X Months: $XXXXXXXXXXXXXXX -$5.70%  
X Year: $XXXXXXXXXXXXXXX -$3.90%  
1-Year High: $XXXXXXXXXXXXXXX on 2025-03-06  
1-Year Low: $XXXXXXXXXXXXXXX on 2025-09-25  

### Top Sanofi News
Top news links shared on social in the last XX hours  

*Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.*  

"US FDA launches fresh safety scrutiny of approved RSV therapies for infants CNN"  
[News Link](https://www.cnn.com/2025/12/09/health/fda-rsv-vaccine-review) [@CNN](/creator/x/CNN) 2025-12-09T22:02Z 60.9M followers, XXX engagements


"Blueprint Medicines a Sanofi Company Highlights Long-Term Clinical Benefit of AYVAKIT (avapritinib) Across Indolent and Advanced Systemic Mastocytosis at 2025 ASH Annual Meeting"  
[News Link](https://www.prnewswire.com/news-releases/blueprint-medicines-a-sanofi-company-highlights-long-term-clinical-benefit-of-ayvakit-avapritinib-across-indolent-and-advanced-systemic-mastocytosis-at-2025-ash-annual-meeting-302633712.html) [@PRNewswire](/creator/x/PRNewswire) 2025-12-05T13:06Z 228.6M followers, 4385 engagements


"Sanofi Raided in French Tax Fraud Probe of SocGen Financing Deal - Bloomberg"  
[News Link](https://www.bloomberg.com/news/articles/2025-11-25/sanofi-raided-in-french-tax-fraud-probe-of-socgen-financing-deal) [@business](/creator/x/business) 2025-11-25T17:28Z 228.6M followers, 11.8K engagements



### Top Sanofi Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"U.S. health regulators informed senior executives at Merck Sanofi and AstraZeneca last week that their approved protective RSV treatments for infants would face fresh safety scrutiny following concerns raised by vaccine skeptics multiple sources familiar with the situation told Reuters"  
[X Link](https://x.com/TheChiefNerd/status/1998635427712860389) [@TheChiefNerd](/creator/x/TheChiefNerd) 2025-12-10T06:06Z 908.5K followers, 6270 engagements


"BREAKING: U.S. health regulators informed senior execs at Merck Sanofi and AstraZeneca last week that their approved protective RSV treatments for infants would face fresh safety scrutiny following concerns raised by vaccine skeptics Reuters"  
[X Link](https://x.com/TheInsiderPaper/status/1998622112681222170) [@TheInsiderPaper](/creator/x/TheInsiderPaper) 2025-12-10T05:13Z 449.3K followers, 7794 engagements


"SBI Magnum Midcap Fund decreased stakes in Suven Pharmaceuticals (-93.52%) Sanofi India (-22.02%) Schaeffler India (-5.98%) Nykaa - FSN E-Commerce Ventures Ltd. (-0.59%) 🧵 #SBIMagnumMidcapFund #SuvenPharmaceuticals #SanofiIndia #SchaefflerIndia"  
[X Link](https://x.com/dumb_investing/status/1998596107912593906) [@dumb_investing](/creator/x/dumb_investing) 2025-12-10T03:30Z XXX followers, XX engagements


"@Daniel_E_Park 11/ Tier-1 banks running short-and-distort JPMorgan $X target despite Sanofi deal BofA downgraded right after RFK comments Citi $X target ignoring $1B+ guidance Consensus says $XXXXX (70% upside) yet price stays crushed = coordinated suppression"  
[X Link](https://x.com/TJMeehan1/status/1998589780662300920) [@TJMeehan1](/creator/x/TJMeehan1) 2025-12-10T03:05Z XX followers, XX engagements